On April 5th, the 22nd Century Group (XXII) signed a three-year exclusive licensing and distribution agreement with global cannabis company Cookies. The agreement covers all non-Delta-9 THC cannabis-derived consumer products of the Cookies brand, including the procurement of all raw materials and APIs, as well as the production and retail distribution of e-cigarettes and other CBD products. In the past three years, the 22nd Century Group's GVB Biopharma has already produced various Cookies products. With this new agreement, they will continue to produce Cookies' leading products and are expected to account for more than half of Cookies' non-Delta-9 THC sales.
The agreement also involves the integration of market sales and distribution, utilizing 22nd Century's senior consumer packaged goods sales team, who plan to distribute Cookies products in up to 18 markets to launch the company's innovative VLN product in 2023. The consumer goods sales team will target around 60,000 retail stores, including independent retailers, discount tobacco outlets, and e-cigarette shops in non-entertainment states, serviced by their top regional distributors and chain discount tobacco store networks. The product will also be available for sale on Cookies' e-commerce website.
22nd Century Group, Inc. is a biotech company focused on altering the nicotine content in tobacco plants and the cannabinoid content in cannabis plants through genetic engineering, gene editing, and modern plant breeding. Its primary goal in the tobacco industry is to introduce cigarettes with 95% less nicotine than traditional cigarettes in the US and international markets.
References:
22nd Century has agreed to a partnership with Cookies.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
